Heterogeneous metabolomic aging across the same age and prediction of health outcome

Xueqing Jia,Jiayao Fan,Xucheng Wu,Xingqi Cao,Lina Ma,Zeinab Abdelrahman,Daniele Bizzarri,Erik B van den Akker,P. Eline Slagboom,Joris Deelen,Dan Zhou,Zuyun Liu

DOI: https://doi.org/10.1101/2024.04.22.24306156

2024-04-22

Abstract:Existing metabolomic clocks exhibit deficiencies in capturing the heterogeneous aging rates among individuals with the same chronological age. Yet, the modifiable and non-modifiable factors in metabolomic aging have not been systematically studied. Here, we leveraged metabolomic profiles of 239,291 UK Biobank participants for 10-year all-cause mortality prediction to generate and validate a new aging measure--MetaboAgeMort. The MetaboAgeMort showed significant associations with all-cause mortality, cause-specific mortality, and diverse incident diseases. Adding MetaboAgeMort to conventional risk factors model improved the predictive ability of 10-year mortality. We identified 99 modifiable factors for MetaboAgeMort, where 16 factors representing pulmonary function, body composition, socioeconomic status, dietary quality, smoking status, alcohol intake, and disease status showed quantitatively stronger associations. The genetic analyses revealed 99 genomic risk loci and 271 genes associated with MetaboAgeMort. Our study illuminates heterogeneous metabolomic aging across the same age, which provides avenues for developing anti-aging therapies and personalized interventions.

Geriatric Medicine

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the deficiency of existing metabolomics clocks in capturing the heterogeneous aging rates among individuals of the same physiological age. Specifically, the paper aims to develop a new aging measurement index - MetaboAgeMort - through large - scale metabolomics data and verify its effectiveness in predicting 10 - year all - cause mortality. In addition, the paper also attempts to systematically study the effects of modifiable and non - modifiable factors on metabolomics aging and reveal its genetic determinants.

### Detailed analysis of the main problems

1. **Limitations of existing metabolomics clocks**:
- Existing metabolomics clocks are mainly based on the correlation between metabolomics features and actual age and cannot fully capture the heterogeneity of aging rates among individuals.
- These clocks rely on cohort - specific standardized biomarker values, which limit their application and comparison in different populations.

2. **Developing a new aging measurement index**:
- To overcome the above limitations, the authors used the large - scale metabolomics data of the UK Biobank (239,291 participants) to develop a new aging measurement index - MetaboAgeMort, which is based on 10 - year all - cause mortality as a surrogate marker.
- MetaboAgeMort is not only significantly associated with all - cause mortality but also associated with the risk of developing multiple diseases, indicating its potential application value in health risk stratification.

3. **Identifying factors affecting metabolomics aging**:
- The researchers systematically identified 99 modifiable factors, which cover aspects such as lung function, body composition, socioeconomic status, diet quality, smoking status, alcohol intake, and disease status.
- Among them, 16 factors showed stronger associations, such as vital capacity, body fat percentage, dietary index, and household income.

4. **Genetic analysis**:
- Through genome - wide association analysis (GWAS), the researchers found that 99 genomic risk loci and 271 genes were significantly associated with MetaboAgeMort.
- These findings reveal the genetic mechanisms of metabolomics aging and provide new ideas for the development of anti - aging therapies.

### Summary

This paper solves the deficiency of existing metabolomics clocks in capturing the heterogeneity of aging among individuals by developing MetaboAgeMort, a new aging measurement index. At the same time, the study also systematically explores the modifiable and genetic determinants of metabolomics aging, providing an important basis for the development of personalized interventions and anti - aging therapies.